Zai Lab Ltd SEC filings ZLAB
Zai Lab Ltd has 739 filings in SEC EDGAR's recent list, going back to May 30, 2017. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| CORRESP | Letter to the SEC | Apr 18, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2024 | — |
| CORRESP | Letter to the SEC | Feb 16, 2024 | — |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| CORRESP | Letter to the SEC | Jan 5, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2023 | — |
| CORRESP | Letter to the SEC | Dec 4, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2022 | — |
| CORRESP | Letter to the SEC | Jan 14, 2022 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Nov 9, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 30, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2020 | — |
| SEC STAFF LETTER | Filing | Aug 25, 2020 | — |
| POSASR | Post-effective amendment no. 1 to form f-3 | Jan 21, 2020 | — |
| CT ORDER | Filing | Sep 12, 2019 | — |
| EFFECT | Filing | Sep 5, 2018 | — |
| CT ORDER | Filing | Sep 5, 2018 | — |
| CORRESP | Letter to the SEC | Aug 31, 2018 | — |
| CORRESP | Letter to the SEC | Aug 31, 2018 | — |
| DRS | Filing | Aug 20, 2018 | — |
| CT ORDER | Filing | May 22, 2018 | — |
| EFFECT | Filing | Sep 20, 2017 | — |
| EFFECT | Filing | Sep 20, 2017 | — |
| CT ORDER | Filing | Sep 20, 2017 | — |
| CORRESP | Letter to the SEC | Sep 15, 2017 | — |
| CORRESP | Letter to the SEC | Sep 15, 2017 | — |
| 8-A12B | Filing | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Aug 22, 2017 | — |
| DRS/A | Filing | Aug 2, 2017 | — |
| DRSLTR | Filing | Aug 1, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2017 | — |
| DRS/A | Filing | Jul 11, 2017 | — |
| DRSLTR | Filing | Jul 10, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2017 | — |
| DRSLTR | Filing | Jun 27, 2017 | — |
| DRS/A | Filing | Jun 27, 2017 | — |
| DRS | Filing | May 31, 2017 | — |
| DRSLTR | Filing | May 30, 2017 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZLAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Shanghai
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1704292
- Former names
- Zai Lab Ltd (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.